In our study, CRP levels and TNF-α levels were significantly decreased, suggesting that ω-3 PUFAs may have some regulatory effect on the inflammatory status in patients treated with lung cancer radiotherapy and chemotherapy. This evidence concerns the gene CRP and lung carcinoma.